Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2006
|
| gptkbp:ATCCode |
A10BH01
|
| gptkbp:CASNumber |
gptkb:486460-32-6
|
| gptkbp:chemicalFormula |
C16H15F6N5O
|
| gptkbp:contraindication |
gptkb:diabetic_ketoacidosis
type 1 diabetes |
| gptkbp:drugClass |
DPP-4 inhibitor
|
| gptkbp:eliminationHalfLife |
12.4 hours
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
gptkb:sitagliptin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Januvia
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
inhibits dipeptidyl peptidase-4
|
| gptkbp:pregnancyCategory |
Category B (US)
|
| gptkbp:proteinBinding |
38%
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
headache
upper respiratory tract infection nasopharyngitis hypoglycemia (when combined with other drugs) |
| gptkbp:usedFor |
gptkb:type_2_diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|